Semintra

Semintra Oral Solution (Telmisartan) is an angiotensin receptor blocker to receive a marketing authorisation in veterinary medicine, and contains the active ingredient Telmisartan. It is prescribed for the reduction of proteinuria (unwanted loss of proteins via the urine) associated with chronic kidney disease in cats.

Always follow the directions of your veterinarian for using Semintra Oral Solution (Telmisartan) to ensure the safest and most effective results. Do not self-medicate or determine these instructions on your own as this may lead to serious or unexpected health problems.

Bring your cat in for regular consultations with the veterinarian to make sure it is getting the correct results from treatment. This will allow its progress and response to medication to be observed so that the correct adjustments can be made to the regimen. These may include reducing its dosage or frequency of administration until the best results occur. If you have any questions about the medicine, ask the pharmacist or veterinarian to ensure the correct usage.

If you witness any unusual symptoms, inform the veterinarian immediately to make sure the correct response is taken. This may include reducing the dosage or frequency of administration to prevent further complications.

Side effects that may occur while using this medication include:

• chest pain
• cough
• dizziness
• fatigue
• muscle aches
• nausea

Do not use Semintra Oral Solution (Telmisartan) in cats that are lactating, pregnant, breeding, blood disorders, or kidney disease.

It is suggested to bring the cat in for a check-up prior to use to make sure it does not have any other conditions that may cause complications with treatment. These can require reduced dosages or other adjustments to the regimen to prevent these potential problems from occurring.